Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new typhoid vaccine for both adults and children has been proven by Oxford researchers, including Prof Brian Angus, to be safe and effective in preventing the disease.

Arm being vaccinated with typhoid vaccine

A study published in The Lancet is the first clinical trial to show that immunisation with a new typhoid conjugate vaccine (TCV) is safe, well tolerated and will have significant impact on disease incidence in typhoid-endemic areas that introduce the vaccine.

Read the full article

Similar stories

3.4 million assays run by NDM’s serology platform

Within weeks of the pandemic starting, the Nuffield Department of Medicine (NDM) began antibody testing as part of the UK’s ONS COVID-19 Infection Survey. The platform successfully tested millions of blood samples over three years, providing invaluable information on how vaccinations and previous infections affect the chance of getting COVID-19 again.